SCHEMBL9997113

SCHEMBL9997113

CCC(=O)Oc1cccc(O)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
KMT2A Q03164 4/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
HPGD P15428 2/20 0.44
MAPK1 P28482 2/20 0.44
HSD17B10 Q99714 2/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
ACHE P22303 3/20 0.44
ALOX15 P16050 2/20 0.41
ESR1 P03372 5/20 0.41
HIF1A Q16665 2/20 0.41
TRPA1 O75762 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL67780 0.85 ALOX15 (0.50) CA12CA1CA2CA7CA9
SCHEMBL1750794 0.84 POLB (0.53) KMT2AKDM4ELMNAHPGDMAPK1
SCHEMBL28679175 0.84 KMT2A (0.49) CA12CA1CA2CA7CA9
SCHEMBL6687247 0.83 KMT2A (0.57) CA12CA1CA2CA7CA9
SCHEMBL361508 0.83 GAA (0.50) CA12CA1CA2CA7CA9
SCHEMBL27669744 0.82 KDM4E (0.44) CA12CA1CA2CA7CA9
Methane SCHEMBL10713153 0.81 GAA (0.48) CA12CA1CA2CA7CA9
SCHEMBL1260106 0.81 KMT2A (0.43) KMT2AKDM4ELMNAHPGDMAPK1
SCHEMBL4795365 0.81 ESR1 (0.42) CA12CA1CA2CA7CA9
SCHEMBL10876865 0.81 CA12 (0.41) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011161646-A2 PROCESS FOR THE PREPARATION OF ALVIMOPAN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF RANBAXY LABORATORIES LIMITED (IN) 2011-12-29 WO claimed
WO-2011161646-A2 PROCESS FOR THE PREPARATION OF ALVIMOPAN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF RANBAXY LABORATORIES LIMITED (IN) 2011-12-29 WO disclosed